159 related articles for article (PubMed ID: 38191325)
1. Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis.
Weigelt J; Petrosyan M; Oliveira-Ferrer L; Schmalfeldt B; Bartmann C; Dietl J; Stürken C; Schumacher U
BMC Cancer; 2024 Jan; 24(1):43. PubMed ID: 38191325
[TBL] [Abstract][Full Text] [Related]
2. Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways.
Ma L; Wei J; Wan J; Wang W; Wang L; Yuan Y; Yang Z; Liu X; Ming L
J Exp Clin Cancer Res; 2019 Feb; 38(1):77. PubMed ID: 30760281
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM).
Duan Y; Yu J; Chen M; Lu Q; Ning F; Gan X; Liu H; Ye Y; Lu S; Lash GE
J Ovarian Res; 2023 Apr; 16(1):81. PubMed ID: 37087461
[TBL] [Abstract][Full Text] [Related]
5. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior.
Wang Y; Dong L; Cui H; Shen DH; Wang Y; Chang XH; Fu TY; Ye X; Yao YY
J Zhejiang Univ Sci B; 2011 May; 12(5):346-56. PubMed ID: 21528488
[TBL] [Abstract][Full Text] [Related]
7. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
8. ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells.
Yu Y; Xu L; Qi L; Wang C; Xu N; Liu S; Li S; Tian H; Liu W; Xu Y; Li Z
Biomed Pharmacother; 2017 Dec; 96():22-29. PubMed ID: 28963947
[TBL] [Abstract][Full Text] [Related]
9. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.
Kleih M; Böpple K; Dong M; Gaißler A; Heine S; Olayioye MA; Aulitzky WE; Essmann F
Cell Death Dis; 2019 Nov; 10(11):851. PubMed ID: 31699970
[TBL] [Abstract][Full Text] [Related]
10. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
11. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
Sharma SK; Sevak KK; Monette S; Carlin SD; Knight JC; Wuest FR; Sala E; Zeglis BM; Lewis JS
J Nucl Med; 2016 May; 57(5):771-6. PubMed ID: 26837339
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
[TBL] [Abstract][Full Text] [Related]
13. TR3 modulates platinum resistance in ovarian cancer.
Wilson AJ; Liu AY; Roland J; Adebayo OB; Fletcher SA; Slaughter JC; Saskowski J; Crispens MA; Jones HW; James S; Fadare O; Khabele D
Cancer Res; 2013 Aug; 73(15):4758-69. PubMed ID: 23720056
[TBL] [Abstract][Full Text] [Related]
14. Role of Hydroxysteroid Dehydrogenase-Like 2 (HSDL2) in Human Ovarian Cancer.
Sun Q; Zhang Y; Su J; Li T; Jiang Y
Med Sci Monit; 2018 Jun; 24():3997-4008. PubMed ID: 29894468
[TBL] [Abstract][Full Text] [Related]
15. HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer.
Guo J; Li X; Zhang W; Chen Y; Zhu S; Chen L; Xu R; Lv Y; Wu D; Guo M; Liu X; Lu W; Deng H
Sci Rep; 2019 Sep; 9(1):12628. PubMed ID: 31477750
[TBL] [Abstract][Full Text] [Related]
16. Selectin-independent adhesion during ovarian cancer metastasis.
Khaustova NA; Maltseva DV; Oliveira-Ferrer L; Stürken C; Milde-Langosch K; Makarova JA; Rodin S; Schumacher U; Tonevitsky AG
Biochimie; 2017 Nov; 142():197-206. PubMed ID: 28919578
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53.
Lu P; Vander Mause ER; Redd Bowman KE; Brown SM; Ahne L; Lim CS
J Ovarian Res; 2019 May; 12(1):45. PubMed ID: 31092272
[TBL] [Abstract][Full Text] [Related]
18. Chrysophanol induces cell death and inhibits invasiveness via mitochondrial calcium overload in ovarian cancer cells.
Lim W; An Y; Yang C; Bazer FW; Song G
J Cell Biochem; 2018 Dec; 119(12):10216-10227. PubMed ID: 30129050
[TBL] [Abstract][Full Text] [Related]
19. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457
[No Abstract] [Full Text] [Related]
20. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
